Limas C
Department of Pathology, Department of Veterans Affairs Medical Center, Minneapolis, MN 55417.
J Pathol. 1993 Sep;171(1):39-47. doi: 10.1002/path.1711710109.
We attempted to investigate how the proliferative state of the urothelium correlates with the reactivity for transferrin (Tf) and epidermal grown factor (EGF) receptors and the blood group (BG) antigen. We examined morphologically normal urothelium (34 cases), benign inflammatory and reactive conditions (24 cases), and atypical changes (20 cases) without exophytic or invasive neoplasia. The Ki67 nuclear antigen was used as the proliferation index and was complemented with the in vitro BrdU incorporation assay in 32 cases. The immunohistochemical reactions for Tf and EGF receptors and for the appropriate BG antigen were scored semi-quantitatively on frozen sections. We found that normal urothelium has very low Ki67 and BrdU indices as well as low reactivity for the two receptors and is almost invariably positive for the BG antigen. Benign conditions such as inflammation and metaplasia significantly augment the proliferation indices and the Tf receptor with little change in the EGF receptor and no significant effect on the BG antigen. Moderate atypia includes biologically heterogeneous cases which vary widely in proliferation and receptor expression. Severe atypia-carcinoma in situ is consistently associated with markedly elevated proliferation indices, strong Tf receptor reactivity, and depressed BG antigen. The reactivity for EGF receptor is less consistently increased. Cases with a combination of strong EGF receptor reactions and absence of the expected BG antigen have a poor prognosis with progression to invasive cancer.
我们试图研究尿路上皮的增殖状态如何与转铁蛋白(Tf)、表皮生长因子(EGF)受体的反应性以及血型(BG)抗原相关。我们检查了形态学上正常的尿路上皮(34例)、良性炎症和反应性病变(24例)以及无外生性或浸润性肿瘤形成的非典型改变(20例)。Ki67核抗原用作增殖指数,并在32例中辅以体外BrdU掺入试验。在冰冻切片上对Tf和EGF受体以及相应BG抗原的免疫组化反应进行半定量评分。我们发现正常尿路上皮的Ki67和BrdU指数非常低,对两种受体的反应性也低,并且几乎总是对BG抗原呈阳性。诸如炎症和化生等良性病变显著增加增殖指数和Tf受体,而EGF受体变化不大,对BG抗原无显著影响。中度非典型增生包括生物学上异质性的病例,其在增殖和受体表达方面差异很大。重度非典型增生——原位癌始终与增殖指数显著升高、Tf受体反应性强以及BG抗原降低相关。EGF受体的反应性增加不太一致。EGF受体反应强且缺乏预期BG抗原的病例预后较差,易进展为浸润性癌。